Just a moment, the page is loading...

Resident Training

Galderma recognizes the importance of supporting residency programs that provide formal and structured on-label injection trainings involving our portfolio of aesthetic injectable products. Results of such activities may lead to greater understanding of the therapeutic areas that we treat, our products and their potential applications, as well as improved patient care.

We accept unsolicited requests for in-kind product grants from ACGME-accredited dermatology, plastic surgery, ophthalmology, or otolaryngology residency programs who are interested in conducting their own on-label injection trainings. Each program may submit 1 request per academic year. Requests are accepted on an ongoing basis, but there are submission deadlines for each semester (see Submission Deadlines in the HOW TO APPLY tab). Please note that submissions/contracts do not automatically renew each academic year.

Residency program trainings should be conducted independently from Galderma; therefore, these grants are limited to the provision of in-kind product support only.

Please note, requests for the 2022-2023 academic year will be accepted beginning on August 1st.

Submit a Request

Galderma is interested in Medical Education (ME) Activities that leads to a greater understanding of the therapeutic areas that we treat, our products and their potential applications, as well as improved patient care. Requests for ME Activity support must align with the company's defined areas of strategic interest. Currently these include:

  • Prescription
    • Acne
    • Rosacea
  • Aesthetics
    • Hyaluronic acid fillers
    • Poly-L-lactic acid (PLLA)
    • Neuromodulators
  • Consumer Skincare
    • Moisturizers
    • Cleansers
    • Acne Medications

For further information on Galderma's areas of interest, please visit www.nestleskinhealth.com/us.

Only the aesthetic injectable products (Dysport®, Restylane® family of products, and Sculptra®) are available for request. To view our current portfolio of products, please visit www.galderma.com/us/our-brands.

Galderma does not provide medical grants to support fellow training. Please contact your local Galderma Sales Representative to request product samples for fellows.

We will not consider requests in support of the following:

  • Non-ACGME-accredited residency programs, or programs outside those listed as being eligible
  • Requests for product to be shipped to a fellow, resident, the program coordinator, any physician's private practice, or a medical facility other than the requesting academic institution
  • Residency programs outside of the U.S.

Residency programs may submit 1 product request per academic year and each program may receive 1 product shipment per semester (fall, spring, and summer) for that school year. Submission deadlines for each semester are enforced. A formal notification will be sent to the requestor with the decision following review of the request (typically within 10 business days following request submission). Should additional information be needed to make a decision, a request for additional information will be issued by email.

Residency

The following information is required for residency product requests:

  • Number of residents in program
  • Academic semesters product will be used
  • Shipping address of the program director

To ensure that we can review and process your request before the end of the semester, the following submission deadlines are enforced:

Semester Deadline
Fall September 30th
Spring March 30th
Summer June 30th

Requests for the new academic year are accepted beginning on August 1st of each year. Submissions/contracts are not automatically renewed. Each program is required to submit a new request each academic year. While requests may be submitted at any time during the school year, support will not be considered for any semesters in your request for which the submission deadline has passed.

If the request is approved, a contract will be sent through DocuSign® for execution between the residency program director and Galderma. Support is contingent upon a fully executed contract, compliance with the terms and conditions of the contract, as well as availability of time within the semester to conduct the product training.

Product is shipped directly to the program director at their academic institution only. Product will not be shipped to a resident, the program coordinator, any physician's private practice, or a medical facility other than the requesting academic institution.

The exact shipping and delivery dates will be determined by Galderma after execution of the Agreement. Deliveries are typically scheduled for Tuesday, Wednesday, or Thursday.

Please be aware that some product may arrive in temperature-sensitive shipments. All efforts should be made to ensure that delivery is intercepted in a timely manner and product is stored appropriately. Galderma will not provide replacement product if product is not handled appropriately once delivered to your organization resulting in the product becoming unusable.

Please note that some products' shelf-lives may not extend the duration of the semester. Upon receipt of the product shipment, expiration dates should be noted and a reasonable attempt to use all of the provided product should be made. Galderma will not replace products that expire prior to the end of a semester given that enough time was allowed for the residency program to reasonably use the product upon receipt. Once the product expires or is no longer viable, the program director should destroy the product at their own expense.

Requests for in-kind product must come directly from the Residency Program Director.

  • The Program Director must be a licensed medical doctor (MD) or a doctor of osteopathic medicine (DO) from an ACGME-accredited dermatology, plastic surgery, otolaryngology, or ophthalmology teaching program.
  • The Program Director must have a valid and current state medical license number.

Galderma does not accept Grant Requests from or for individual physicians or groups of physicians.

The following information is required to submit a request for in-kind product:

  • Number of Residents in Program; and
  • Quantity of In-Kind Product Requested From Galderma.

Upon approval of a request, Galderma will enter into a Letter of Agreement (LOA) with the Academic Institution as the Activity Provider. All Medical Education (ME) activities supported by Galderma must abide by the terms of Galderma's LOA; no other LOAs will be accepted. Galderma may not provide in-kind product support to the Academic Institution until a Letter of Agreement (LOA) has been fully executed. Please note that, the LOA must be executed with a reasonable amount of time left in the semester for the product training to be conducted to use the product.

The LOA requires the Academic Institution to:

  • Retain control over the design and conduct of the Activity;
  • Conduct the Activity independently, without any influence from Galderma;
  • Ensure that the Activity is unbiased, objective, and addresses all relevant treatment options, rather than focusing on a single product;
  • Provide meaningful disclosure to the audience (i.e., disclosure that is reasonably calculated to reach the relevant audience in a manner that will alert them to potential biases) at the beginning of the Activity regarding Galderma's financial support and acknowledge Galderma as a source of funding for the Activity in any written materials; and
  • Make available a reasonable opportunity for discussion and a question-and-answer session at the end of the Activity.

Product is shipped directly to the Program Director at their Academic Institution only. Product will not be shipped to a resident, the Program Coordinator, any physician's private practice, or a medical facility other than the requesting Academic Institution.

The exact shipping and delivery dates will be determined by Galderma after an internal review and execution of a LOA between Galderma and the Residency Program Director on behalf of the Academic Institution as the Activity Provider. Deliveries are typically scheduled for Tuesday, Wednesday, or Thursday.

Please be aware that Dysport® has specific temperature requirements for shipping and storing. All efforts should be made to ensure that delivery is intercepted in a timely manner, as replacement product will not be provided if a delivery is missed by the Academic Institution and the product becomes no longer viable. Care should be taken to ensure that Dysport® is protected from light and that temperature control at 2°C, 8°C (36°F, 46°F) is maintained during shipping and storing.

Please note that some products' shelf-lives may not extend the duration of the semester. Upon receipt of the product(s), the Residency Program Director shall note the expiration dates and make a reasonable attempt to use all of the products provided. Galderma will not replace products that expire prior to the end of a semester given that enough time was allowed for the residency program to reasonably use the product. Once the product expires or is no longer viable, the Program Director may destroy the product at their own expense.

We are committed to maintaining integrity in all of our professional relationships. We operate under the highest ethical standards and in full compliance with all applicable laws, regulations, industry codes, and guidelines. Approval of in-kind support is never related to or conditioned upon past or future prescriptions or purchases of Galderma products. Furthermore, we do not offer, or provide funding to encourage or to reward the prescription, purchase, ordering, or recommending of Galderma products.

Our grant review and approval process is in full accordance with the recommendations and the guidance of the US Food and Drug Administration (FDA), the Accreditation Council for Continuing Medical Education (ACCME), the Office of Inspector General (OIG) Compliance Program Guidance for Pharmaceutical Manufacturers, the PhRMA Code on Interaction with Health Care Professionals, the AdvaMed Code of Ethics on Interactions with Health Care Providers, and National Physician Payment Transparency Program: Open Payments "Physician Payment Sunshine Act", as well as internal Galderma policies.

By submitting your request for review, you agree that the information is not confidential, nor proprietary, and may be referred to a number of different persons at Galderma to determine the level of interest in supporting your request.

Disclosure of in-kind support must be provided to the learners prior to the beginning of the educational activity, in one or more of the following: program brochures, syllabi, and other program materials, and at the time of the activity. This disclosure will not include the use of a trade name, product-group message or commercial interest's logo. The acknowledgment of commercial support may state the name of the company only.

© 2024 Galderma Laboratories, L.P. All Rights Reserved. The Dysport® trademark is used under license. All trademarks are the property of their respective owners. This website is intended for U.S. audiences only. Information in this website is not intended as, and is not, medical advice to you. Talk to your medical doctor about your medical condition.